Electroconvulsive therapy (ECT) is one of the most effective and safe treatments for severe refractory mental diseases, including psychosis, mood disorder, and catatonia. Widespread cognitive complications as unintended consequences of ECT have affected the acceptance of this treatment (
1). Despite current evidence supporting short-term cognitive impairment after ECT, long-term cognition consequences are less determined (
2). Although the severity and persistence of these cognitive complications are still debated, a proper clinical neuropsychiatric assessment should be used as a part of ECT. However, in different guidelines, the frequency and content of these cognitive assessments are still unclear (
3,
4).
Cognitive impairment related to ECT predominantly affects recent memory, executive function, and attention. Cognitive alterations are most severe in the acute phase, significantly a few hours to a few days after ECT, and usually improve partially after the end of treatment (
5,
6). Unfortunately, in numerous cases, a comprehensive cognitive assessment is not performed before ECT to determine which patients are at risk of exacerbated cognition problems (
7). Moreover, patients’ cognitive function is not evaluated in the follow-up assessment. Furthermore, these cognitive tests are performed in cases of severe cognitive decline, delirious state, and patient’s disruptive function (
8,
9).
Cognitive function monitoring after ECT is helpful to detect cognitive impairment. A meta-analysis suggests that the most prevalent domain of impairment is new learning which could return to baseline after 2 weeks. Other cognitive domains could be preserved (
10). The selection of the applicable test is still under question. Some studies use instruments with short duration and other tools with longer duration. A battery that lasts less than an hour seems to be more tolerated by patients.
The Delis-Kaplan Executive Function System (D-KEFS) is a standard tool to evaluate executive performance in different age groups and assess different areas of executive function, including flexibility of thought, inhibition, problem-solving, planning, impulse control, conceptualization, abstract thinking, and creativity. The D-KEFS consists of nine completely separate tests that can be used alone or in combination.
The Auditory Verbal Learning Test is one of the most common psychological tests in memory assessment and auditory-verbal learning that assesses the ability of individuals to encode, consolidate, store, and retrieve verbal information and the effect of interfering stimuli, delayed memory, and recognition (
11). The Trail Making Test was utilized in a study that was correlated with hippocampal volume (
12).
The lack of cognitive assessment can be due to a lack of knowledge about the extent and severity of cognitive complications, lack of expertise in cognitive assessment, and lack of resources and facilities for a complete evaluation, patient intolerance, and the patient’s disability to perform neuropsychological tests (
13,
14). Cognitive impairment after ECT could be related to the patient’s performance. Cognitive deficits have a significant influence on the patients’ quality of life and create social isolation (
15). The results of these assessments might lead to changes in the ECT method, including the electrodes’ location, electricity dose, treatment frequency, or even its termination. The choice of appropriate time and frequency of cognitive assessment after ECT is still questionable (
10,
16). However, using tools with shorter duration alongside more frequent assessments make it more likely to detect probable cognitive decline. Some guidelines, such as American Psychological Association guidelines, suggest cognitive assessment for at least once a week, and some consider an interval of at least once every two ECT sessions (
17).